Ticker
ESPRCompany Name
ESPERION THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | Interest Expense | Interest Coverage |
---|---|---|---|
6/30/2025 | $ -32.6M | $ 71.42M | -0.46 |
3/31/2025 | $ -88.56M | $ 64.66M | -1.37 |
12/31/2024 | $ 7.51M | $ 59.25M | 0.13 |
9/30/2024 | $ -28.89M | $ 57.89M | -0.5 |
6/30/2024 | $ -40.7M | $ 57.8M | -0.7 |
3/31/2024 | $ -27.89M | $ 58.61M | -0.48 |
12/31/2023 | $ -150.27M | $ 58.98M | -2.55 |
9/30/2023 | $ -150.14M | $ 58.25M | -2.58 |
6/30/2023 | $ -164.85M | $ 57.41M | -2.87 |
3/31/2023 | $ -181.51M | $ 57.13M | -3.18 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Int. Exp.
(=) Int. Coverage
Int. Coverage for ESPERION THERAPEUTICS INC is calculated as follows: EBIT [ $ -83.16M ] / Int. Exp. [ $ 17.86M ]
(=) Int. Coverage [ -4.66 ]
Minimum
Jun 30, 2021
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 2.37K |
---|---|
min | -25.49 |
max | 28.75 |
average | 2.16 |
median | 2.09 |
std | 8.45 |